These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16943448)

  • 21. Acid-induced unfolding of the amino-terminal domains of the lethal and edema factors of anthrax toxin.
    Krantz BA; Trivedi AD; Cunningham K; Christensen KA; Collier RJ
    J Mol Biol; 2004 Nov; 344(3):739-56. PubMed ID: 15533442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular dynamics simulations of complexes between wild-type and mutant anthrax protective antigen variants and a model anthrax toxin receptor.
    Stiles L; Nelson DJ
    J Biomol Struct Dyn; 2005 Apr; 22(5):503-19. PubMed ID: 15702923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anthrax toxins.
    Mourez M
    Rev Physiol Biochem Pharmacol; 2004; 152():135-64. PubMed ID: 15549606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mapping the anthrax protective antigen binding site on the lethal and edema factors.
    Lacy DB; Mourez M; Fouassier A; Collier RJ
    J Biol Chem; 2002 Jan; 277(4):3006-10. PubMed ID: 11714723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural basis for the unfolding of anthrax lethal factor by protective antigen oligomers.
    Feld GK; Thoren KL; Kintzer AF; Sterling HJ; Tang II; Greenberg SG; Williams ER; Krantz BA
    Nat Struct Mol Biol; 2010 Nov; 17(11):1383-90. PubMed ID: 21037566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of N-terminal fragments of anthrax edema factor (EF(N)) and lethal factor (LF(N)) to the protective antigen pore.
    Leuber M; Kronhardt A; Tonello F; Dal Molin F; Benz R
    Biochim Biophys Acta; 2008 Jun; 1778(6):1436-43. PubMed ID: 18243126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anthrax lethal factor (LF) mediated block of the anthrax protective antigen (PA) ion channel: effect of ionic strength and voltage.
    Neumeyer T; Tonello F; Dal Molin F; Schiffler B; Orlik F; Benz R
    Biochemistry; 2006 Mar; 45(9):3060-8. PubMed ID: 16503661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activity of the Bacillus anthracis 20 kDa protective antigen component.
    Hammamieh R; Ribot WJ; Abshire TG; Jett M; Ezzell J
    BMC Infect Dis; 2008 Sep; 8():124. PubMed ID: 18808698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trapping a translocating protein within the anthrax toxin channel: implications for the secondary structure of permeating proteins.
    Basilio D; Jennings-Antipov LD; Jakes KS; Finkelstein A
    J Gen Physiol; 2011 Apr; 137(4):343-56. PubMed ID: 21402886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stoichiometry of anthrax toxin complexes.
    Mogridge J; Cunningham K; Collier RJ
    Biochemistry; 2002 Jan; 41(3):1079-82. PubMed ID: 11790132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three-dimensional model of the pore form of anthrax protective antigen. Structure and biological implications.
    Nguyen TL
    J Biomol Struct Dyn; 2004 Dec; 22(3):253-65. PubMed ID: 15473701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A model of anthrax toxin lethal factor bound to protective antigen.
    Lacy DB; Lin HC; Melnyk RA; Schueler-Furman O; Reither L; Cunningham K; Baker D; Collier RJ
    Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16409-14. PubMed ID: 16251269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anthrax protective antigen: efficiency of translocation is independent of the number of ligands bound to the prepore.
    Zhang S; Cunningham K; Collier RJ
    Biochemistry; 2004 May; 43(20):6339-43. PubMed ID: 15147218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of membrane translocation by anthrax protective antigen.
    Wesche J; Elliott JL; Falnes PO; Olsnes S; Collier RJ
    Biochemistry; 1998 Nov; 37(45):15737-46. PubMed ID: 9843379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Solution Structures of
    Michelman-Ribeiro A; Rubinson KA; Silin V; Kasianowicz JJ
    Toxins (Basel); 2021 Dec; 13(12):. PubMed ID: 34941724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ion selectivity of the anthrax toxin channel and its effect on protein translocation.
    Schiffmiller A; Anderson D; Finkelstein A
    J Gen Physiol; 2015 Aug; 146(2):183-92. PubMed ID: 26170174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proton-coupled protein transport through the anthrax toxin channel.
    Finkelstein A
    Philos Trans R Soc Lond B Biol Sci; 2009 Jan; 364(1514):209-15. PubMed ID: 18957378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Asymmetric Cryo-EM Structure of Anthrax Toxin Protective Antigen Pore with Lethal Factor N-Terminal Domain.
    Machen AJ; Akkaladevi N; Trecazzi C; O'Neil PT; Mukherjee S; Qi Y; Dillard R; Im W; Gogol EP; White TA; Fisher MT
    Toxins (Basel); 2017 Sep; 9(10):. PubMed ID: 28937604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein translocation through anthrax toxin channels formed in planar lipid bilayers.
    Zhang S; Udho E; Wu Z; Collier RJ; Finkelstein A
    Biophys J; 2004 Dec; 87(6):3842-9. PubMed ID: 15377524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trp 346 and Leu 352 residues in protective antigen are required for the expression of anthrax lethal toxin activity.
    Batra S; Gupta P; Chauhan V; Singh A; Bhatnagar R
    Biochem Biophys Res Commun; 2001 Feb; 281(1):186-92. PubMed ID: 11178978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.